Edition:
United Kingdom

Shanghai Shyndec Pharmaceutical Co Ltd (600420.SS)

600420.SS on Shanghai Stock Exchange

8.54CNY
16 Aug 2019
Change (% chg)

¥0.00 (+0.00%)
Prev Close
¥8.54
Open
¥8.51
Day's High
¥8.62
Day's Low
¥8.48
Volume
2,809,690
Avg. Vol
4,130,555
52-wk High
¥11.71
52-wk Low
¥8.07

Latest Key Developments (Source: Significant Developments)

Shanghai Shyndec Pharmaceutical's 2018 Net Profit Up 36.8 Percent Y/Y
Thursday, 18 Apr 2019 

April 18 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>::SAYS 2018 NET PROFIT UP 36.8 PERCENT Y/Y AT 705.5 MILLION YUAN ($105.21 million).  Full Article

Shanghai Shyndec Pharmaceutical's Preliminary 2018 Net Profit Up 37.8 Percent Y/Y
Tuesday, 22 Jan 2019 

Jan 22 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>::SAYS PRELIM 2018 NET PROFIT UP 37.8 PERCENT Y/Y AT 710.8 MILLION YUAN ($104.43 million).  Full Article

Shanghai Shyndec Pharmaceutical to pay cash dividend of 0.5 yuan (pre-tax) for every 10 shares
Thursday, 22 Mar 2018 

March 22 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says it plans to pay a cash dividend of 0.5 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017.  Full Article

Shanghai Shyndec Pharmaceutical's 2017 Net Profit Up 8.2 Pct Y/Y At 515.8 Mln Yuan
Wednesday, 21 Mar 2018 

March 21 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>::SAYS 2017 NET PROFIT UP 8.2 PERCENT Y/Y AT 515.8 MILLION YUAN ($81.51 million).  Full Article

Shanghai Shyndec Pharmaceutical unit obtains high-tech enterprise recognition and to enjoy tax preference
Thursday, 8 Feb 2018 

Feb 8 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS> : :Says its wholly owned unit was recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years from 2017 to 2019.  Full Article

Shanghai Shyndec Pharmaceutical announces change of president
Monday, 15 Jan 2018 

Jan 15(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says Zhou Bin resigned from president .Says it appoints Yang Jun as new president of the company .  Full Article

Shanghai Shyndec Pharmaceutical unit receives GMP certificate
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says Shantou-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration and the valid period is until Jan. 3, 2023 .Certificate issued to unit's products including troche, hard capsule and granula.  Full Article

Shanghai Shyndec Pharmaceutical unit receives GMP certificate
Monday, 8 Jan 2018 

Jan 8(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says its 55 percent-owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .Certificate issued to freeze-dried powder injection manufactured by the unit and the valid period is until Dec. 12, 2022.  Full Article

Shanghai Shyndec Pharmaceutical injects capital of 50 mln yuan into pharmaceutical unit
Tuesday, 2 Jan 2018 

Jan 2(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says co injects capital of 50 million yuan into co's Wuhan-based pharmaceutical unit and raises stake in the unit to 96.95 percent from 96.16 percent .  Full Article

Shanghai Shyndec Pharmaceutical's 9-month net profit up 16.1 pct y/y
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd <600420.SS>:Says 9-month net profit up 16.1 percent y/y at 446.0 million yuan ($67.22 million).  Full Article